Prestige Consumer Healthcare, Inc. (PBH)
45.26
+0.49
(+1.09%)
USD |
NYSE |
Oct 02, 16:00
45.28
+0.02
(+0.04%)
Pre-Market: 20:00
Prestige Consumer Healthcare Market Cap : 2.144B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.144B |
| October 01, 2026 | 2.121B |
| September 30, 2026 | 2.173B |
| September 29, 2026 | 2.214B |
| September 28, 2026 | 2.223B |
| September 25, 2026 | 2.208B |
| September 24, 2026 | 2.163B |
| September 23, 2026 | 2.175B |
| September 22, 2026 | 2.261B |
| September 21, 2026 | 2.217B |
| September 18, 2026 | 2.130B |
| September 17, 2026 | 2.201B |
| September 16, 2026 | 2.220B |
| September 15, 2026 | 2.211B |
| September 14, 2026 | 2.256B |
| September 11, 2026 | 2.224B |
| September 10, 2026 | 2.243B |
| September 09, 2026 | 2.307B |
| September 08, 2026 | 2.359B |
| September 04, 2026 | 2.476B |
| September 03, 2026 | 2.490B |
| September 02, 2026 | 2.503B |
| September 01, 2026 | 2.494B |
| August 31, 2026 | 2.453B |
| August 28, 2026 | 2.486B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.426B |
| August 26, 2026 | 2.470B |
| August 25, 2026 | 2.437B |
| August 24, 2026 | 2.464B |
| August 21, 2026 | 2.431B |
| August 20, 2026 | 2.393B |
| August 19, 2026 | 2.448B |
| August 18, 2026 | 2.396B |
| August 17, 2026 | 2.370B |
| August 14, 2026 | 2.434B |
| August 13, 2026 | 2.431B |
| August 12, 2026 | 2.476B |
| August 11, 2026 | 2.539B |
| August 10, 2026 | 2.511B |
| August 07, 2026 | 2.598B |
| August 06, 2026 | 2.578B |
| August 05, 2026 | 2.510B |
| August 04, 2026 | 2.463B |
| August 03, 2026 | 2.457B |
| July 31, 2026 | 2.376B |
| July 30, 2026 | 2.364B |
| July 29, 2026 | 2.470B |
| July 28, 2026 | 2.447B |
| July 27, 2026 | 2.385B |
| July 24, 2026 | 2.350B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.465B |
| Structure Therapeutics, Inc. | 1.971B |
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
Market Cap Related Metrics
| PE Ratio | 12.67 |
| PS Ratio | 1.973 |
| Price to Book Value | 1.119 |
| Price to Free Cash Flow | 9.261 |
| Price | 45.26 |
| Earnings Yield | 7.89% |
| Operating PE Ratio | 7.512 |
| Normalized PE Ratio | 12.67 |